Aggregated
50% success rate- Bullish
- 5
- Hold
- 2
- Bearish
- 0
Guggenheim
A Guggenheim analyst with 8 tracked ratings across 8 distinct tickers has a 50% success rate on the captured sample, covering both sources in their analysis.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| ERAS | 2025-11-14 | buy | $5.00 | Aggregated |
| MRUS | 2025-09-30 | hold | $97.00 | Aggregated |
| MRUSMERUS N.V | 2025-09-30 | hold | $97.00 | Aggregated |
| GMAB | 2025-09-24 | buy | $43.00 | Aggregated |
| GMABGENMAB - ADR | 2025-09-24 | unknown | $43.00 | Aggregated |
| EXEL | 2025-07-29 | buy | $45.00 | Aggregated |
| EXELEXELIXIS INC | 2025-07-29 | unknown | $45.00 | Aggregated |
| RVMD | 2024-10-28 | buy | $82.00 | Aggregated |
| RVMDREVOLUTION MEDICINES INC | 2024-10-28 | unknown | $82.00 | Aggregated |
| ARVN | 2023-11-20 | buy | $40.00 | Aggregated |
| ARVNARVINAS INC | 2023-11-20 | unknown | $40.00 | Aggregated |
| BPMC | 2022-11-02 | buy | $85.00 | Aggregated |
| BPMCBLUEPRINT MEDICINES CORP | 2022-11-02 | unknown | $85.00 | Aggregated |
| Aggregated |
| RVMDREVOLUTION MEDICINES INC | 1 | 2024-10-28 | Aggregated |
| ARVN | 2 | 2023-11-20 | Aggregated |
| ARVNARVINAS INC | 1 | 2023-11-20 | Aggregated |
| BPMC | 2 | 2022-11-02 | Aggregated |
| BPMCBLUEPRINT MEDICINES CORP | 1 | 2022-11-02 | Aggregated |